ATC's LADARVision PRK Laser Recommended For Approval
This article was originally published in The Gray Sheet
Executive Summary
Autonomous Technologies Corp.'s LADARVision laser vision correction device provides superior post-operative uncorrected visual acuity to pre-operative best spectacle corrected visual acuity in approximately 20% of patients, according to data submitted by the Orlando, Florida-based firm in support of its September 1997 premarket approval application.
You may also be interested in...
IPO Year In Review: Record-Year Bodes Well For 2021, And For More SPACs
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott Capitalizes On Pandemic Testing Boom; Device Sales Stay Almost Flat
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
Agios’ Mitapivat Shows Improvement In Regularly Transfused PKD Patients
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: